Tirzepatide, currently marketed by Eli Lilly (NYSE:LLY) as Mounjaro and Zepbound for diabetes and weight loss, respectively, ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...

Pivotal Peptides says it offers research-grade tirzepatide ... from selling their versions of Eli Lilly's blockbuster weight loss and diabetes drugs. The agency said in a court filing it would ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Tirzepatide is one of a group of weight-loss drugs known as GLP-1 receptor agonists ... potential risks when used for the ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...